Oudard, S.; Benhamouda, N.; Escudier, B.; Ravel, P.; Tran, T.; Levionnois, E.; Negrier, S.; Barthelemy, P.; Berdah, J.F.; Gross-Goupil, M.;
et al. Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma. Cells 2022, 11, 17.
https://doi.org/10.3390/cells11010017
AMA Style
Oudard S, Benhamouda N, Escudier B, Ravel P, Tran T, Levionnois E, Negrier S, Barthelemy P, Berdah JF, Gross-Goupil M,
et al. Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma. Cells. 2022; 11(1):17.
https://doi.org/10.3390/cells11010017
Chicago/Turabian Style
Oudard, Stephane, Nadine Benhamouda, Bernard Escudier, Patrice Ravel, Thi Tran, Emeline Levionnois, Sylvie Negrier, Philippe Barthelemy, Jean François Berdah, Marine Gross-Goupil,
and et al. 2022. "Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma" Cells 11, no. 1: 17.
https://doi.org/10.3390/cells11010017
APA Style
Oudard, S., Benhamouda, N., Escudier, B., Ravel, P., Tran, T., Levionnois, E., Negrier, S., Barthelemy, P., Berdah, J. F., Gross-Goupil, M., Sternberg, C. N., Bono, P., Porta, C., De Giorgi, U., Parikh, O., Hawkins, R., Highley, M., Wilke, J., Decker, T.,
... Tartour, E.
(2022). Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma. Cells, 11(1), 17.
https://doi.org/10.3390/cells11010017